HDAC4 and urothelial carcinoma: Furthermore, evidence shows that overexpression of HDAC4 does not typically enhance urothelial carcinoma cell proliferation, suggesting that targeting HDAC4 with HDACis may not be effective in treating urothelial carcinoma [49].